Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275327 · ClinicalTrials.gov registry record
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 300
- Enrollment target
NCT00275327 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 300 participants.
The verdict
NCT00275327 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
o determine if extended-spectrum beta-lactamases, plasmid-mediated AmpC beta-lactamases, carbapenemases, chromosomal mutations in ribosomal RNA or other mechanisms of resistance account for antibiotic resistance in commonly encountered Gram negative and Gram positive bacteria at UPMC. Also to determine the molecular epidemiology and in vitro susceptibility of multiply resistant organisms at UPMC and to relate this to antibiotic use in the institution.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2006-01 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00275327
The ClinicalTrials.gov registry entry for NCT00275327 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00275327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00275327 about?
NCT00275327 is a clinical study titled "Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria". o determine if extended-spectrum beta-lactamases, plasmid-mediated AmpC beta-lactamases, carbapenemases, chromosomal mutations in ribosomal RNA or other mechanisms of resistance account for antibiotic resistance in commonly encountered Gram negative and Gram positive bacteria at UPMC. Also to determ...
What is the current status of trial NCT00275327?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2006-01. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00275327?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.